Acacia Pharma has generated a pipeline of product opportunities addressing a range of cancer supportive care indications, such as nausea & vomiting, xerostomia and cachexia, using a commercially driven approach to product development by identifying new uses for already marketed drugs Acacia Pharma is focused on cancer supportive care - the management of the symptoms of cancer, or the side effects of cancer therapy Acacia Pharma is backed by Gilde Healthcare Partners, Lundbeckfond Ventures, management and private investors